I am not saying for or against NP, but he is NOT a maverick if one understands the definition. He is not doing anything unorthodox or "out of the box" in terms of trying to figure out some way to run a successful trial and bring leronlimab to market. He is merely going from possibility to possibility after failing at each one before, while hopefully learning a little something from each failure as the window for some indications grows smaller and smaller. As the saying goes, "Try again, fail again, fail better." (Samuel Beckett)